Eltropag 25 mg Tablet Substitute
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
ELTROMBOPAG-25MG
Uses:
Eltropag 25 mg Tablet is used to treat low platelet count and severe aplastic anemia (SAA). The detailed uses of Eltropag 25 mg Tablet are as follows:<br/>• Chronic immune thrombocytopenia (ITP): Eltropag 25 mg Tablet helps prevent excessive bleeding in patients with low platelet counts.<br/>• Severe aplastic anemia: Eltropag 25 mg Tablet is used to treat severe aplastic anemia when other tratments have failed.<br/>• Chronic hepatitis C-related thrombocytopenia: Eltropag 25 mg Tablet helps maintain platelet levels before and during interferon therapy.<br/>
Medicinal Benefits:
Eltropag 25 mg Tablet contains 'Eltrombopag,' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections, and severe aplastic anemia (SAA). Eltropag 25 mg Tablet works by increasing megakaryocytes, the large bone marrow cells responsible for the production of platelets. The increase in these bone marrow cells stimulates the production of platelets. Thus, Eltropag 25 mg Tablet prevents bleeding episodes by increasing the number of platelets in the blood.
Eltropag 25 mg Tablet is used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. It is also used to treat severe aplastic anemia (SAA).
Eltropag 25 mg Tablet contains Eltrombopag that stimulates platelet production (helps in clotting) from megakaryocytes (bone marrow cells). Thus Eltropag 25 mg Tablet lowers the risk of bleeding episodes in diseases like immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections, and severe aplastic anemia (SAA).
Do not stop using Eltropag 25 mg Tablet even if you feel better. It should be strictly used as advised by your doctor to avoid the recurrence of symptoms and worsening of the disease.
Eltropag 25 mg Tablet should be used with caution and only under doctor supervision in cases if you are having any allergic reactions, blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, liver or kidney diseases.
Eltropag 25 mg Tablet decreases the risk of bleeding by increasing the platelet count in your body. However, you are advised to stay away from activities that may increase your risk of bleeding like contact sports and using sharp objects like razors and nail cutters.
It is advised to take Eltropag 25 mg Tablet on an empty stomach. Please take Eltropag 25 mg Tablet at least two hours before or four hours after consuming antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminium, selenium, and zinc), dairy products, calcium-enriched foods, and fortified juices since they interfere with the absorption of Eltropag 25 mg Tablet.
It is usually taken by mixing the prescribed amount of suspension powder in water and administering it orally immediately after ensuring perfect mixing.
Eltropag 25 mg Tablet should be stored in a cool and dry place away from sunlight. Keep out of sight and reach of children.
Eltropag 25 mg Tablet can cause or increase the risk of severe liver issues. Check with your doctor straight away if you experience nausea or vomiting, dark urine, light-coloured stools, right upper stomach pain, unusual exhaustion, or yellow eyes or skin while using this medication.